TY - JOUR
T1 - Clinical presentation of stage IIIA (N2) non-small cell lung cancer
T2 - Role of multimodality therapy cancer
AU - Friedberg, Joseph S.
PY - 1999
Y1 - 1999
N2 - Neoadjuvant chemotherapy before surgical resection of locally advanced non-small cell lung cancer (NSCLC) has been shown to improve survival compared with surgery alone in several randomized clinical trials. A case report is presented describing the use of paclitaxel and carboplatin in a multimodality regimen for a patient with stage IIIA N2 NSCLC. Studies are ongoing to determine the optimal type and timing of chemotherapy.
AB - Neoadjuvant chemotherapy before surgical resection of locally advanced non-small cell lung cancer (NSCLC) has been shown to improve survival compared with surgery alone in several randomized clinical trials. A case report is presented describing the use of paclitaxel and carboplatin in a multimodality regimen for a patient with stage IIIA N2 NSCLC. Studies are ongoing to determine the optimal type and timing of chemotherapy.
KW - Multimodality therapy
KW - Neoadjuvant chemotherapy
KW - Non-small cell lung cancer
KW - Stage IIIA N2 disease
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=0033398523&partnerID=8YFLogxK
U2 - 10.1378/chest.116.suppl_3.497s
DO - 10.1378/chest.116.suppl_3.497s
M3 - Article
C2 - 10619518
AN - SCOPUS:0033398523
SN - 0012-3692
VL - 116
SP - 497S-499S
JO - Chest
JF - Chest
IS - 6 SUPPL.
ER -
